Affiliated Hospital of Nantong University
🇨🇳China
Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 426
- Registration Number
- NCT06732427
- Locations
- 🇨🇳
Yongtao Gao, Nantong, Jiangsu, China
Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 60
- Registration Number
- NCT06690424
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
Phase 4
Recruiting
- Conditions
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 64
- Registration Number
- NCT06690307
- Locations
- 🇨🇳
Affiliated hospital of Nantong University, Nantong, Jiangsu, China
Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment.
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 5
- Registration Number
- NCT06676267
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 83
- Registration Number
- NCT06643962
- Locations
- 🇨🇳
Affiliated hospital of Nantong University, Nantong, Jiangsu, China
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 30
- Registration Number
- NCT06643793
Good-first: B/F/TAF As First-line ART
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 630
- Registration Number
- NCT06619288
- Locations
- 🇨🇳
Nantong Third Peoples Hospital, Nantong, Jiangsu, China
Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 30
- Registration Number
- NCT06574204
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 10
- Registration Number
- NCT06560086
- Locations
- 🇨🇳
Affiliated hospital of nantong university, Nantong, Jiangsu, China
Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients With Treatment-naive Non-GCB DLBCL
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 30
- Registration Number
- NCT06530511
- Locations
- 🇨🇳
Jiangsu Province Hospital, Nanjing, China
© Copyright 2024. All Rights Reserved by MedPath